Dr. Matthew Hardwick; GLP & Infection Control

Dr. Matthew Hardwick, PhD

Thought Leader & Subject Matter Expert — GLP & Infection Control

About Matthew Hardwick (Matt)

Dr. Matthew Hardwick, infection prevention expert at iAIR Labs, GLP, FDA and EPA
Dr. Matthew Hardwick is a senior research leader at iAIR Labs, specialising in antimicrobial efficacy, infection prevention, and Good Laboratory Practice (GLP) studies.

Dr. Matt Hardwick is a GLP-focused microbiologist and infection-control specialist. He advises the iAIR Healthgroup on best-practice study design, regulatory-ready data, and antimicrobial/antiviral efficacy methods for products and built environments.

Matt’s work spans surface and device testing, decontamination technologies (including UV-C), and practical infection-risk reduction strategies.

He is a co-author of the peer-reviewed Journal of Research of the National Institute of Standards and Technology study on UV-C disinfection of N95 respirators, and is known for translating rigorous laboratory science into defensible, real-world claims that bridge regulatory compliance and public health outcomes.

Past President & CEO, ResInnova Laboratories

Expertise and GLP

GLP Study Design

GLP study design and quality assurance across regulatory-facing research programmes.

Efficacy Testing

Antimicrobial and antiviral efficacy testing for products and materials.

Infection Prevention

Infection prevention strategies in healthcare and indoor environments.

UV-C & Decontamination

UV-C and decontamination technologies, including respirator disinfection research.

Claims Substantiation

Regulatory-ready validation and claims substantiation for market access.

Selected Publication

Poster DL, Hardwick M, et al. Disinfection of Respirators with Ultraviolet Radiation. Journal of Research of NIST. 2022;126:126058. https://doi.org/10.6028/jres.126.058

Collaboration Focus at Airmid on GLP & Infection Control

  • GLP-aligned protocols for antimicrobial and antiviral testing
  • Infection-control method development in Airmid’s aerobiology chambers
  • Evidence frameworks for product claims and market access

Accreditation & Compliance

iAIR Labs offers high-quality testing, inspection, compliance and certification across several regulatory systems. Our labs are routinely, externally audited to ensure that your data is reliable, repeatable, and scientifically accurate. We meet the requirements for submission to both the US EPA and the US FDA. Whether you’re interested in early R&D for your product or GLP testing for a 510(k), contact us with your testing needs.

Good Laboratory Practices (GLP)
The Good Laboratory Practices were enacted as law in 1978 to ensure that all data submitted to federal regulatory agencies is performed safely and reliably. The GLPs were introduced to assure that a study is conducted by qualified personnel working in well-maintained facilities with appropriate materials and calibrated equipment, using properly designed experiments recorded with clear and complete detailed documentation, overseen by an independent Quality Assurance Unit, and safely archived for audit/inspection by regulatory agents.

EPA GLP
EPA Good Laboratory Practices (GLP) ensures the quality and integrity of test data submitted to the Environmental Protection Agency. The EPA writes regulations, provides guidance, reviews submitted data, inspects for compliance, registers toxic materials, and enforces legal action for violations.

FDA GLP
FDA GLP prescribes good laboratory practices for conducting nonclinical laboratory studies that support or are intended to support applications for research or marketing permits for products regulated by the Food and Drug Administration (FDA). This program supports customers requesting a GLP assessment, as the FDA does not provide a certificate of compliance.

At iAIR Labs, we pride ourselves on adhering to the highest standards of regulatory compliance. All our testing services are conducted in strict accordance with FDA and EPA guidelines and cGLP (current Good Laboratory Practice) regulations, ensuring our clients receive results that are both reliable and recognised by regulatory bodies.

Discuss Your GLP & Infection Control Testing Needs

Contact Airmid Healthgroup to speak with our team about antimicrobial, antiviral, or GLP testing requirements for your product or technology.

Get in Touch

Frequently Asked Questions

What is Dr. Matthew Hardwick’s area of expertise?

He specialises in GLP study design, antimicrobial and antiviral efficacy testing, infection prevention, and UV-C decontamination technologies.

What role does Matt play at Airmid Healthgroup?

He advises on best-practice study design, regulatory-ready data, and antimicrobial/antiviral efficacy methods for products and built environments.

What notable research has he published?

He is a co-author of a peer-reviewed study in the Journal of Research of NIST on UV-C disinfection of N95 respirators.

What was his role prior to joining Airmid?

He served as Past President & CEO of ResInnova Laboratories.

What is his collaboration focus at Airmid?

He focuses on GLP-aligned protocols for antimicrobial and antiviral testing, infection-control method development in Airmid’s aerobiology chambers, and evidence frameworks for product claims and market access.

Related Reading

  • Reflections on the ASHRAE Winter Meeting: Infectious Aerosols, Standard 241, and Healthy Buildings — explores how ASHRAE Standard 241 establishes new benchmarks for controlling infectious aerosols in indoor environments.
  • Airmid Healthgroup’s Collaboration on Hand Hygiene and Indoor Air Quality — highlights research connecting surface hygiene, hand drying, and airborne pathogen control.
  • Revolutionizing Aerosol Detection with the Wideband Integrated Bioaerosol Sensor (WIBS) — examines how advanced sensors are transforming real-time bioaerosol monitoring and infection-control science.

Related Services and Tests for GLP

Submit Your Enquiry

This field is for validation purposes and should be left unchanged.
Contact Name(Required)
Scroll to Top